CLINICAL_TRIALS
trial_result
· 2024-10-01
Clinical Trial Update: Impact of Discontinuing Hypertonic Saline in People With CF on Highly Effective CFTR Modulators- A SIMPLIFY Sub-Study [NA]
Summary
A SIMPLIFY sub-study evaluated the effects of discontinuing hypertonic saline in people with cystic fibrosis who are on highly effective CFTR modulators.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Nicole Hamblett | Conditions: Cystic Fibrosis | NA | Status: COMPLETED | Results posted: 2024-10-01